Table 4 Tumor characteristics in relation to self-reported milk production
Table 4 | All patients | Nulliparous | Milk production of first child -Almost no milk | Milk production of first child -Insufficient | Milk production of first child -Adequate | Milk production of first child -Excessive | Ptrend |
|---|---|---|---|---|---|---|---|
n=592 | n=89 | n=25 | n=129 | n=245 | n=79 | ||
n (percent) | n (percent) | n (percent) | n (percent) | n (percent) | n (percent) | ||
pT | 0.79 | ||||||
0 | 14 (2.4%) | 3 (3.4%) | 2 (8.0%) | 2 (1.6%) | 3 (1.2%) | 1 (1.3%) | |
1 | 424 (71.6%) | 61 (68.5%) | 15 (60.0%) | 89 (69.0%) | 185 (75.5%) | 57 (72.2%) | |
2 | 144 (24.3%) | 23 (25.8%) | 8 (32.0%) | 36 (27.9%) | 54 (22.0%) | 19 (24.1%) | |
3 | 9 (1.5%) | 2 (2.2%) | 0 | 2 (1.6%) | 3 (1.2%) | 2 (2.5%) | |
4 | 1 (0.2%) | 0 | 0 | 0 | 0 | 0 | |
Number of axillary lymph nodes | 0.14 | ||||||
0 | 368 (62.4%) | 61 (68.5%) | 18 (72.0%) | 81 (62.8%) | 151 (61.9%) | 43 (55.1%) | |
1-3 | 167 (28.3%) | 21 (23.6%) | 4 (16.0%) | 38 (29.5%) | 72 (29.5%) | 24 (30.8%) | |
4+ | 55 (9.3%) | 7 (7.9%) | 3 (12.0%) | 10 (7.8%) | 21 (8.6%) | 11 (14.1%) | |
Missing | 2 | 0 | 0 | 0 | 1 | 1 | |
Histologic grade | 0.29 | ||||||
I | 157 (26.6%) | 22 (24.7%) | 11 (44.0%) | 31 (24.2%) | 66 (26.9%) | 23 (29.1%) | |
II | 308 (52.1%) | 47 (52.8%) | 12 (48.0%) | 73 (57.0%) | 123 (50.2%) | 39 (49.4%) | |
III | 126 (21.3%) | 20 (22.5%) | 2 (8.0%) | 24 (18.8%) | 56 (22.9%)' | 17 (21.5%) | |
Missing | 1 | 0 | 0 | 1 | 0 | 0 | |
Hormone receptor status | |||||||
ER+ | 502 (86.7%) | 76 (88.4%) | 22 (95.7%) | 108 (84.4%) | 207 (85.9%) | 71 (91.0%) | 0.68 |
ER- | 77 (13.3%) | 10 (11.6%) | 1 (4.3%) | 20 (15.6%) | 34 (14.1%) | 7 (9.0%) | |
PgR+ | 402 (69.4%) | 61 (70.9%) | 18 (78.3%) | 85 (66.4%) | 162 (67.2%) | 58 (74.4%) | 0.70 |
PgR- | 177 (30.6%) | 25 (29.1) | 5 (21.7%) | 43 (33.6%) | 79 (32.8%) | 20 (25.6%) | |
Missing | 13 | 3 | 2 | 1 | 4 | 1 | |
ER+ PgR+ | 398 (68.7%) | 60 (69.8%) | 18 (78.3%) | 85 (66.4%) | 159 (66.0%) | 58 (74.4%) | 0.76 |
ER+ PgR- | 104 (18.0%) | 16 (18.6%) | 4 (17.4%) | 23 (18.0%) | 48 (19.9%) | 13 (16.7%) | 0.98 |
ER- PgR+ | 4 (0.7%) | 1 (1.2%) | 0 | 0 | 3 (1.2%) | 0 | 0.65 |
ER- PgR- | 73 (12.6%) | 9 (10.5%) | 1 (4.3%) | 20 (15.6%) | 31 (12.9%) | 7 (9.0%) | 0.60 |
Missing | 13 | 3 | 2 | 1 | 4 | 1 |